Venezuelan equine encephalitis virus in the guinea pig model: Evidence for epizootic virulence determinants outside the E2 envelope glycoprotein gene

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 3, 2005, Pages 330-338

  Greene, Ivorlyne P ^a   Paessler, Slobodan ^b   Anishchenko, Michael ^b   Smith, Darci R ^b   Brault, Aaron C ^c   Frolov, Ilya ^b   Weaver, Scott C ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; UNCLASSIFIED DRUG; VIRUS ENVELOPE GLYCOPROTEIN E2; VIRUS GLYCOPROTEIN; COMPLEMENTARY DNA; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; ENVELOPE GENE; EPIDEMIC; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GUINEA PIG; HORSE; LYMPHOID TISSUE; MOSQUITO; NONHUMAN; PHENOTYPE; PHYLOGENY; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIREMIA; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; BONE MARROW; BRAIN; CERCOPITHECUS; DISEASE MODEL; DISEASE TRANSMISSION; ENCEPHALOMYELITIS; GENETIC TRANSCRIPTION; GENETICS; ISOLATION AND PURIFICATION; LYMPH NODE; PATHOGENICITY; PATHOLOGY; SPLEEN; VERO CELL; VIROLOGY; VIRULENCE;

ANIMALIA; CAVIA; CAVIA PORCELLUS; EQUIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

ANIMALS; BONE MARROW; BRAIN; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; DNA, VIRAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; GUINEA PIGS; LYMPH NODES; SPLEEN; TRANSCRIPTION, GENETIC; VERO CELLS; VIRULENCE;

EID: 18244398221     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.330     Document Type: Article

References (51)

1. Kinney RM, Johnson BJ, Welch JB, Tsuchiya KR, Trent DW, 1989. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 170: 19-30.
2. Strauss JH, Strauss EG, 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58: 491-562.
3. Young NA, Johnson KM, 1969. Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am J Epidemiol 89: 286-307.
4. Rico-Hesse R, Weaver SC, de Siger J, Medina G, Salas RA, 1995. Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America. Proc Natl Acad Sci U S A 92: 5278-5281.
5. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, Tesh RB, 1996. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 348: 436-440.
6. Oberste MS, Fraire M, Navarro R, Zepeda C, Zarate ML, Ludwig GV, Kondig JF, Weaver SC, Smith JF, Rico-Hesse R, 1998. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico. Am J Trop Med Hyg 59: 100-107.
7. Hawley RJ, Eitzen EM Jr, 2001. Biological weapons-a primer for microbiologists. Annu Rev Microbiol 55: 235-253.
8. Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA, 2002. Biological and chemical agents: a brief synopsis. Am J Ther 9: 5-14.
9. Walton TE, Grayson MA, 1988. Venezuelan equine encephalomyelitis. Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Volume IV. Boca Raton, FL: CRC Press, 203-231.
10. Johnson KM, Martin DH, 1974. Venezuelan equine encephalitis. Adv Vet Sci Comp Med 18: 79-116.
11. Aguilar PV, Greene IP, Coffey LL, Medina G, Moncayo AC, Anishchenko M, Ludwig GV, Turell MJ, O'Guinn ML, Lee J, Tesh RB, Watts DM, Russell KL, Hice C, Yanoviak S, Morrison AC, Klein TA, Dohm DJ, Guzman H, Travassos da Rosa AP, Guevara C, Kochel T, Olson J, Cabezas C, Weaver SC, 2004. Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis 10: 880-888.
12. Wang E, Bowen RA, Medina G, Powers AM, Kang W, Chandler LM, Shope RE, Weaver SC, 2001. Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains. Am J Trop Med Hyg 65: 64-69.
13. Walton TE, Alvarez O, Buckwalter RM, Johnson KM, 1973. Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus. J Infect Dis 128: 271-282.
14. Sudia WD, Newhouse VF, Henderson BE, 1971. Experimental infection of horses with three strains of Venezuelan equine encephalomyelitis virus. II. Experimental vector studies. Am J Epidemiol 93: 206-211.
15. Leon CA, 1975. Sequelae of Venezuelan equine encephalitis in humans: a four year follow-up. Int J Epidemiol 4: 131-140.
16. Garcia-Tamayo J, Carreno G, Esparza J, 1979. Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in the rat. J Pathol 128: 87-91.
17. Aronson JF, Grieder FB, Davis NL, Charles PC, Knott T, Brown K, Johnston RE, 2000. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Virology 270: 111-123.
18. Davis NL, Brown KW, Greenwald GF, Zajac AJ, Zacny VL, Smith JF, Johnston RE, 1995. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 212: 102-110.
19. Kinney RM, Chang GJ, Tsuchiya KR, Sneider JM, Roehrig JT, Woodward TM, Trent DW, 1993. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′-noncoding region and the E2 envelope glycoprotein. J Virol 67: 1269-1277.
20. Powers AM, Brault AC, Kinney RM, Weaver SC, 2000. The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants. J Virol 74: 4258-4263.
21. Wang E, Barrera R, Boshell J, Ferro C, Freier JE, Navarro JC, Salas R, Vasquez C, Weaver SC, 1999. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J Virol 73: 4266-4271.
22. Anishchenko M, Paessler S, Greene IP, Aguilar PV, Carrara A, Weaver SC, 2004. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus. J Virol 78: 1-8.
23. Cupp EW, Scherer WF, Lok JB, Brenner RJ, Dziem GM, Ordonez JV, 1986. Entomological studies at an enzootic Venezuelan equine encephalitis virus focus in Guatemala, 1977-1980. Am J Trop Med Hyg 35: 851-859.
24. Cupp EW, Scherer WF, Ordonez JV, 1979. Transmission of Venezuelan encephalitis virus by naturally infected Culex (Melanoconion) opisthopus. Am J Trop Med Hyg 28: 1060-1063.
25. Brault AC, Powers AM, Weaver SC, 2002. Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol 76: 6387-6392.
26. Rice CM, Levis R, Strauss JH, Huang HV, 1987. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol 61: 3809-3819.
27. Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ, 1997. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230: 300-308.
28. Lennette EH, Lennette DA, Lennette ET, 1995. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. Washington, DC: American Public Health Association.
29. Brault AC, Powers AM, Holmes EC, Woelk CH, Weaver SC, 2002. Positively charged amino acid substitutions in the E2 envelope glycoprotein are associated with the emergence of Venezuelan equine encephalitis virus. J Virol 76: 1718-1730.
30. Martin DH, Dietz WH, Alvaerez O Jr, Johnson KM, 1982. Epidemiological significance of Venezuelan equine encephalomyelitis virus in vitro markers. Am J Trop Med Hyg 31: 561-568.
31. Gleiser CA, Gochenour JWS, Berge TO, Tigertt WD, 1961. The comparative pathology of experimental Venezuelan equine encephalitis infection in different animal hosts. J Infect Dis 110: 80-97.
32. Jackson AC, SenGupta SK, Smith JF, 1991. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet Pathol 28: 410-418.
33. Gorelkin L, Jahrling PB, 1975. Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. Lab Invest 32: 78-85.
34. Gorelkin L, Jahrling PB, 1974. Pancreatic involvement by Venezuelan equine encephalomyelitis virus in the hamster. Am J Pathol 75: 349-362.
35. Jahrling PB, 1976. Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. J Gen Virol 32: 121-128.
36. Jahrling PB, Scherer F, 1973. Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. Am J Pathol 72: 25-38.
37. Scherer WF, Chin J, 1977. Responses of guinea pigs to infections with strains of Venezuelan encephaltis virus, and correlations with equine virulence. Am J Trop Med Hyg 26: 307-312.
38. Bernard KA, Klimstra WB, Johnston RE, 2000. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276: 93-103.
39. Spotts DR, Reich RM, Kalkhan MA, Kinney RM, Roehrig JT, 1998. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5′ noncoding region and glycoproteins. J Virol 72: 10286-10291.
40. Grieder FB, Davis NL, Aronson JF, Charles PC, Sellon DC, Suzuki K, Johnston RE, 1995. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206: 994-1006.
41. Dubuisson J, Lustig S, Ruggli N, Akov Y, Rice CM, 1997. Genetic determinants of Sindbis virus neuroinvasiveness. J Virol 71: 2636-2646.
42. Tucker PC, Lee SH, Bui N, Martinie D, Griffin DE, 1997. Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells. J Virol 71: 6106-6112.
43. Dropulic LK, Hardwick JM, Griffin DE, 1997. A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication. J Virol 71: 6100-6105.
44. Frolova EI, Fayzulin RZ, Cook SH, Griffin DE, Rice CM, Frolov I, 2002. Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J Virol 76: 11254-11264.
45. Paessler S, Fayzulin RZ, Anishchenko M, Greene IP, Weaver SC, Frolov I, 2003. Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol 77: 9278-9286.
46. Fazakerley JK, Boyd A, Mikkola ML, Kaariainen L, 2002. A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus. J Virol 76: 392-396.
47. Ahola T, Kujala P, Tuittila M, Blom T, Laakkonen P, Hinkkanen A, Auvinen P, 2000. Effects of palmitoylation of replicase protein nsP1 on alphavirus infection. J Virol 74: 6725-6733.
48. Tuittila M, Hinkkanen AE, 2003. Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence. J Gun Virol 84: 1525-1533.
49. Tarbatt CJ, Glasgow GM, Mooney DA, Sheahan BJ, Atkins GJ, 1997. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. J Gen Virol 78: 1551-1557.
50. Santagati MG, Maatta JA, Roytta M, Salmi AA, Hinkkanen AE, 1998. The significance of the 3′-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice. Virology 243: 66-77.
51. Santagati MG, Maatta JA, Itaranta PV, Salmi AA, Hinkkanen AE, 1995. The Semliki Forest virus E2 gene as a virulence determinant. J Gen Virol 76: 47-52.